| Year |
Citation |
Score |
| 2023 |
Driss LB, Lian J, Walker RG, Howard JA, Thompson TB, Rubin LL, Wagers AJ, Lee RT. GDF11 and aging biology - controversies resolved and pending. The Journal of Cardiovascular Aging. 3. PMID 38235060 DOI: 10.20517/jca.2023.23 |
0.592 |
|
| 2023 |
Lian J, Walker RG, D'Amico A, Vujic A, Mills MJ, Messemer KA, Mendello KR, Goldstein JM, Leacock KA, Epp S, Stimpfl EV, Thompson TB, Wagers AJ, Lee RT. Functional substitutions of amino acids that differ between GDF11 and GDF8 impact skeletal development and skeletal muscle. Life Science Alliance. 6. PMID 36631218 DOI: 10.26508/lsa.202201662 |
0.65 |
|
| 2020 |
Walker RG, Kattamuri C, Goebel EJ, Zhang F, Hammel M, Tainer JA, Linhardt RJ, Thompson TB. Heparin-mediated dimerization of follistatin. Experimental Biology and Medicine (Maywood, N.J.). 1535370220966296. PMID 33197333 DOI: 10.1177/1535370220966296 |
0.723 |
|
| 2019 |
McCoy JC, Walker RG, Murray NH, Thompson TB. Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11. The Journal of Biological Chemistry. PMID 30814254 DOI: 10.1074/Jbc.Ra118.005831 |
0.775 |
|
| 2018 |
Walker RG, Thompson TB. New insight into Hyperemesis Gravidarum and a potential role for GDF15. Endocrinology. PMID 29846562 DOI: 10.1210/En.2018-00439 |
0.505 |
|
| 2018 |
Walker RG, McCoy JC, Czepnik M, Mills MJ, Hagg A, Walton KL, Cotton TR, Hyvönen M, Lee RT, Gregorevic P, Harrison CA, Thompson TB. Molecular characterization of latent GDF8 reveals mechanisms of activation. Proceedings of the National Academy of Sciences of the United States of America. PMID 29348202 DOI: 10.1073/Pnas.1714622115 |
0.753 |
|
| 2017 |
Melchior JT, Walker RG, Cooke AL, Morris J, Castleberry M, Thompson TB, Jones MK, Song HD, Rye KA, Oda MN, Sorci-Thomas MG, Thomas MJ, Heinecke JW, Mei X, Atkinson D, et al. A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state. Nature Structural & Molecular Biology. PMID 29131142 DOI: 10.1038/Nsmb.3501 |
0.605 |
|
| 2017 |
Walker RG, Czepnik M, Goebel EJ, McCoy JC, Vujic A, Cho M, Oh J, Aykul S, Walton KL, Schang G, Bernard DJ, Hinck AP, Harrison CA, Martinez-Hackert E, Wagers AJ, et al. Structural basis for potency differences between GDF8 and GDF11. Bmc Biology. 15: 19. PMID 28257634 DOI: 10.1186/S12915-017-0350-1 |
0.677 |
|
| 2016 |
Walker RG, Poggioli T, Katsimpardi L, Buchanan SM, Oh J, Wattrus S, Heidecker B, Fong YW, Rubin LL, Ganz P, Thompson TB, Wagers AJ, Lee RT. Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation. Circulation Research. 118: 1125-42. PMID 27034275 DOI: 10.1161/Circresaha.116.308391 |
0.683 |
|
| 2016 |
Melchior JT, Walker RG, Morris J, Jones MK, Segrest JP, Lima DB, Carvalho PC, Gozzo FC, Castleberry M, Thompson TB, Davidson WS. An Evaluation of the Crystal Structure of C-terminal Truncated Apolipoprotein A-I in Solution Reveals Structural Dynamics Related to Lipid Binding. The Journal of Biological Chemistry. PMID 26755744 DOI: 10.1074/Jbc.M115.706093 |
0.629 |
|
| 2015 |
Li N, Yang Q, Walker RG, Thompson TB, Du M, Rodgers BD. MYOSTATIN ATTENUATION IN VIVO REDUCES ADIPOSITY, BUT ACTIVATES ADIPOGENESIS. Endocrinology. en20151546. PMID 26580671 DOI: 10.1210/En.2015-1546 |
0.578 |
|
| 2015 |
Poggioli T, Vujic A, Yang P, Macias-Trevino C, Uygur AN, Loffredo FS, Pancoast JR, Cho M, Goldstein J, Tandias RM, Gonzalez E, Walker RG, Thompson TB, Wagers AJ, Fong YW, et al. Circulating Growth Differentiation Factor 11/8 Levels Decline with Age. Circulation Research. PMID 26489925 DOI: 10.1161/Circresaha.115.307521 |
0.637 |
|
| 2015 |
Deng X, Walker RG, Morris J, Davidson WS, Thompson TB. Role of Conserved Proline Residues in Human Apolipoprotein A-IV Structure and Function. The Journal of Biological Chemistry. 290: 10689-702. PMID 25733664 DOI: 10.1074/Jbc.M115.637058 |
0.686 |
|
| 2015 |
Walker RG, Angerman EB, Kattamuri C, Lee YS, Lee SJ, Thompson TB. Alternative binding modes identified for growth and differentiation factor-associated serum protein (GASP) family antagonism of myostatin. The Journal of Biological Chemistry. 290: 7506-16. PMID 25657005 DOI: 10.1074/Jbc.M114.624130 |
0.709 |
|
| 2015 |
Walker RG, Thompson TB. Fibronectin-based scaffold domain proteins that bind myostatin: a patent evaluation of WO2014043344. Expert Opinion On Therapeutic Patents. 25: 619-24. PMID 25632990 DOI: 10.1517/13543776.2015.1007954 |
0.654 |
|
| 2014 |
Walker RG, Deng X, Melchior JT, Morris J, Tso P, Jones MK, Segrest JP, Thompson TB, Davidson WS. The structure of human apolipoprotein A-IV as revealed by stable isotope-assisted cross-linking, molecular dynamics, and small angle x-ray scattering. The Journal of Biological Chemistry. 289: 5596-608. PMID 24425874 DOI: 10.1074/Jbc.M113.541037 |
0.674 |
|
| 2014 |
Rodgers BD, Wiedeback BD, Hoversten KE, Jackson MF, Walker RG, Thompson TB. Myostatin stimulates, not inihibits, C2C12 myoblast proliferation. Endocrinology. 155: 670-5. PMID 24424069 DOI: 10.1210/En.2013-2107 |
0.617 |
|
| 2012 |
Zhang F, Beaudet JM, Luedeke DM, Walker RG, Thompson TB, Linhardt RJ. Analysis of the interaction between heparin and follistatin and heparin and follistatin-ligand complexes using surface plasmon resonance. Biochemistry. 51: 6797-803. PMID 22809401 DOI: 10.1021/Bi300804G |
0.66 |
|
| Show low-probability matches. |